Alchemab Therapeutics

Description: Alchemab develops protective antibodies for hard-to-treat diseases like cancer & neurodegeneration, leveraging global patient data.

Country: UK

Based in: London

Founded: 2018

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Medical', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.